HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazuo Okumoto Selected Research

Kazuo Okumoto Research Topics

Disease

7Fibrosis (Cirrhosis)
03/2022 - 02/2002
6Hepatocellular Carcinoma (Hepatoma)
07/2022 - 12/2003
5Chronic Hepatitis C
11/2013 - 10/2007
4Neoplasms (Cancer)
07/2022 - 12/2003
2Liver Cirrhosis (Hepatic Cirrhosis)
01/2021 - 12/2013
2Disease Progression
11/2016 - 08/2011
2Acute Liver Failure (Fulminant Hepatic Failure)
07/2014 - 08/2007
2Liver Diseases (Liver Disease)
12/2013 - 08/2009
2Insulin Resistance
07/2013 - 08/2009
2Infections
07/2013 - 10/2004
2Hepatitis
03/2009 - 10/2004
2Chronic Hepatitis (Chronic Active Hepatitis)
12/2003 - 09/2003
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
04/2024
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
04/2024
1Rheumatoid Arthritis
04/2024
1Hepatic Encephalopathy
03/2022
1Atrophy
01/2022
1Rare Diseases (Rare Disease)
01/2020
1Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
01/2020
1Liver Failure
11/2016
1Portal Hypertension
11/2016
1Gaucher Disease (Gaucher's Disease)
01/2013
1Metabolic Syndrome (Dysmetabolic Syndrome X)
08/2009
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
03/2009
1Inflammation (Inflammations)
10/2007
1Low Back Pain (Lumbago)
10/2007
1Spondylitis
10/2007
1Fever (Fevers)
10/2007
1Communicable Diseases (Infectious Diseases)
10/2007
1Neoplasm Metastasis (Metastasis)
11/2005
1Needlestick Injuries (Needlestick Injury)
10/2004
1Viremia
04/2004
1Necrosis
12/2003
1Hematoma
09/2003
1Hepatitis B
02/2002

Drug/Important Bio-Agent (IBA)

5InterferonsIBA
11/2013 - 10/2007
3CytokinesIBA
11/2016 - 12/2003
3Ribavirin (Virazole)FDA LinkGeneric
11/2013 - 10/2007
2lenvatinibIBA
07/2022 - 01/2022
2Antiviral Agents (Antivirals)IBA
01/2021 - 11/2013
2RNA (Ribonucleic Acid)IBA
08/2011 - 09/2003
2Human Serum AlbuminFDA LinkGeneric
08/2011 - 12/2003
2Alanine Transaminase (SGPT)IBA
08/2009 - 04/2004
1Methotrexate (Mexate)FDA LinkGeneric
04/2024
1DNA (Deoxyribonucleic Acid)IBA
04/2024
1AlbuminsIBA
07/2022
1BilirubinIBA
07/2022
1Rifaximin (L 105)FDA Link
03/2022
1Fibrinogen (Factor I)FDA Link
01/2020
1MicroRNAs (MicroRNA)IBA
11/2016
1EpiregulinIBA
07/2014
1KetonesIBA
07/2013
1ProlactinIBA
07/2013
1Messenger RNA (mRNA)IBA
07/2013
1Biomarkers (Surrogate Marker)IBA
09/2011
1Collagen Type IV (Type IV Collagen)IBA
09/2011
1Interferon-betaIBA
08/2011
1AdiponectinIBA
08/2009
1LDL CholesterolIBA
08/2009
1Inosine Triphosphate (ITP)IBA
03/2009
1Interferon-alpha (Interferon Alfa)IBA
10/2007
1Stem Cell FactorIBA
08/2007
1Thrombopoietin (c-mpl Ligand)IBA
08/2007
1NucleotidesIBA
10/2004
1Epidermal Growth Factor (EGF)IBA
04/2004
1Interleukin-4 (Interleukin 4)IBA
04/2004
1Transforming Growth Factor beta1 (TGF beta 1)IBA
02/2004
1AcidsIBA
12/2003
1Interleukin-10 (Interleukin 10)IBA
12/2003
1Indicators and Reagents (Reagents)IBA
12/2003
1Lamivudine (Epivir)FDA Link
02/2002

Therapy/Procedure

6Therapeutics
07/2022 - 10/2007
1Lasers (Laser)
11/2016
1Enzyme Replacement Therapy
01/2013
1Laminectomy
08/2011
1Radiofrequency Ablation
11/2005
1Sclerotherapy
09/2003